论文部分内容阅读
目的:观察中西医结合疗法治疗慢性盆腔炎的临床效果。方法:选择167例慢性盆腔炎患者随机分为2组。对照组82例仅采用抗生素等常规西药进行治疗,观察组85例则在对照组治疗的基础上联合桂枝茯苓胶囊、康妇消炎栓进行治疗。统计2组的用药时间、症状消失时间、治疗费用,观察症状积分变化,比较2组的临床疗效、复发率及不良反应发生率。结果:观察组的治愈率为61.18%,总有效率为95.29%,均显著高于对照组的13.41%、84.15%,差异均有统计学意义(P<0.05)。观察组的用药时间、症状消失时间、治疗费用等均短(少)于对照组,差异均有统计学意义(P<0.05)。治疗后,2组症状积分均较治疗前下降(P<0.05),观察组症状积分低于对照组(P<0.05)。观察组患者随访半年的复发率为7.06%,明显低于对照组的18.29%,差异有统计学意义(P<0.05)。观察组不良反应发生率为11.76%,低于对照组的32.93%,差异有统计学意义(P<0.05)。结论:中西医结合治疗慢性盆腔炎,可显著缩短治疗时间,降低治疗费用,提高临床疗效。
Objective: To observe the clinical effect of integrated traditional Chinese and western medicine in the treatment of chronic pelvic inflammatory disease. Methods: 167 patients with chronic pelvic inflammatory disease were randomly divided into two groups. 82 cases in the control group were treated with conventional western medicine such as antibiotics only. 85 cases in the observation group were treated with Guizhi Fuling Capsule and Kangfu Anti-inflammatory suppository on the basis of the treatment of the control group. The time of treatment, the disappearance of symptoms, the treatment cost and the change of symptom score were compared between the two groups. The clinical efficacy, recurrence rate and incidence of adverse reactions in the two groups were compared. Results: The cure rate was 61.18% in the observation group and the total effective rate was 95.29%, which were significantly higher than those in the control group (13.41%, 84.15%, respectively). The difference was statistically significant (P <0.05). The observation group of medication time, symptoms disappear time, treatment costs were shorter (less) in the control group, the difference was statistically significant (P <0.05). After treatment, symptom score of both groups decreased compared with that before treatment (P <0.05), symptom score of observation group was lower than that of control group (P <0.05). The recurrence rate in observation group was 7.06% in six months follow-up, which was significantly lower than that in control group (18.29%, P <0.05). The incidence of adverse reactions in the observation group was 11.76%, which was lower than that in the control group (32.93%), the difference was statistically significant (P <0.05). Conclusion: Integrative Medicine in the treatment of chronic pelvic inflammatory disease can significantly shorten the treatment time, reduce treatment costs and improve clinical efficacy.